XML 78 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Valuation Assumptions
The following table includes the weighted- average assumptions used in estimating the fair values and the resulting weighted-average fair value of stock options granted in the periods presented:
 
Year Ended December 31, 2018
 
Year Ended December 31, 2017
 
Year Ended December 31, 2016
Weighted average fair values of stock options granted
$
11.80

 
$
15.38

 
$
19.50

Expected volatility
35.7
%
 
37.9
%
 
55.5
%
Expected dividends
.70
%
 
.56
%
 
.61
%
Weighted average risk-free interest rate
2.47
%
 
1.64
%
 
1.40
%
Expected life of stock options (in years)
3.5

 
3.5

 
3.5

Schedule of Stock Options Activity
A summary of stock option activity for the years ended December 31, 2018, 2017 and 2016 is as follows:
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Term (Years)
 
Aggregate Intrinsic
Value
 
 
 
 
 
 
 
(in thousands)
Outstanding at January 1, 2016
139,878

 
$
15.17

 
2.32
 
$
2,465

Granted
42,000

 
$
49.22

 
 
 
 
Exercised
(72,379
)
 
$
11.38

 
 
 
 
Canceled

 


 
 
 
 
Outstanding at December 31, 2016
109,499

 
$
30.73

 
3.28
 
$
2,882

Granted
42,000

 
$
53.90

 
 
 
 
Exercised
(3,500
)
 
$
14.90

 
 
 
 
Canceled

 


 
 
 
 
Outstanding at December 31, 2017
147,999

 
$
37.68

 
2.94
 
$
6,152

Granted
42,000

 
$
42.56

 
 
 
 
Exercised
(27,999
)
 
$
15.65

 
 
 
 
Canceled

 


 
 
 
 
Outstanding at December 31, 2018
162,000

 
$
42.75

 
3.05
 
$

Exercisable at December 31, 2018
80,250

 
$
38.21

 
2.00
 
$
49

Schedule of Nonvested Share Activity
A summary of non-vested options and changes for the years ended December 31, 2018, 2017 and 2016 is as follows:

 
Non-Vested Number of Shares
 
Weighted
Average
Exercise Price
 
 
 
 
Non-vested balance at January 1, 2016
75,750

 
$
19.27

Granted
42,000

 
$
49.22

Vested
(43,125
)
 
$
18.89

Canceled

 
$

Non-vested balance at December 31, 2016
74,625

 
$
36.35

Granted
42,000

 
$
53.90

Vested
(40,125
)
 
$
32.54

Canceled

 
$

Non-vested balance at December 31, 2017
76,500

 
$
47.99

Granted
42,000

 
$
42.56

Vested
(36,750
)
 
$
43.52

Canceled

 
$

Non-vested balance at December 31, 2018
81,750

 
$
47.21

Schedule of Shares Authorized under Stock Option Plans, by Exercise Price Range
The following table summarizes information about stock options outstanding by price range as of December 31, 2018:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number Outstanding
 
Weighted-Average Remaining Contractual Life (Years)
 
Weighted-Average Exercise Price
 
Number of Shares
 
Weighted-Average Exercise Price
$21.19
 
30,000

 
0.19
 
$
3.93

 
30,000

 
$
7.92

$28.59
 
6,000

 
0.05
 
$
1.06

 
5,625

 
$
2.00

$42.56
 
42,000

 
1.30
 
$
11.03

 

 
$

$49.22
 
42,000

 
0.61
 
$
12.76

 
28,875

 
$
17.71

$53.90
 
42,000

 
0.91
 
$
13.97

 
15,750

 
$
10.58

 
 
162,000

 
3.05
 
$
42.75

 
80,250

 
$
38.21

Schedule of Nonvested Restricted Stock Activity
A summary of the status of the Company’s non-vested restricted stock grant shares is presented in the following table:

 
Shares
 
Weighted-Average Grant Date
Fair Value
Non vested at January 1, 2016
203,314

 
$
25.56

Granted
26,119

 
$
44.79

Vested
(101,441
)
 
$
23.25

Forfeited
(4,338
)
 
$
35.54

Non vested at December 31, 2016
123,654

 
$
31.17

Granted
56,251

 
$
56.75

Vested
(72,810
)
 
$
29.50

Forfeited

 
$

Non vested at December 31, 2017
107,095

 
$
45.74

Granted
5,623

 
$
76.47

Vested
(68,788
)
 
$
40.67

Forfeited
(3,514
)
 
$
46.24

Non vested at December 31, 2018
40,416

 
$
58.60